SILTUXIMAB vs SIMEPREVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SILTUXIMAB vs SIMEPREVIR: Safety Overview
| Metric | SILTUXIMAB | SIMEPREVIR |
|---|---|---|
| Total FAERS Reports | 472 | 6,029 |
| Deaths Reported | 89 | 372 |
| Death Rate | 18.9% | 6.2% |
| Hospitalizations | 145 | 1,165 |
| Average Patient Age | 47.4 yrs | 60.6 yrs |
| % Female Patients | 56.9% | 43.0% |
| FDA Approval Date | N/A | Nov 22, 2013 |
| Manufacturer | Recordati Rare Diseases, Inc. | N/A |
| Route | INTRAVENOUS | N/A |
| Marketing Status | Prescription | Discontinued |